In a landmark development for the field of structural biology and biophysics, the Biophysics Collaborative Access Team (BioCAT) at the Advanced Photon Source (APS) has secured a substantial $2.6 million renewal award from the National Institute of General Medical Sciences (NIGMS). This funding ensures the continuation of BioCAT’s cutting-edge operations at Sector 18-ID of Argonne National Laboratory for the next five years. Spearheaded by Illinois Institute of Technology faculty members—including Professors Thomas Irving, Weikang Ma, and Jesse Hopkins—BioCAT remains a pivotal national resource that facilitates advanced X-ray scattering and diffraction studies critical to understanding the complex machinery of life.
BioCAT has earned its reputation as one of the world’s premier synchrotron facilities by specializing in methods that probe the structure and dynamics of biological entities in conditions that closely emulate their natural, living states. Unlike traditional crystallographic techniques that require proteins and other macromolecules to be crystallized, many vital biological complexes remain elusive without such formation. BioCAT’s sophisticated beamline integrates techniques such as fiber diffraction, micro-diffraction, and small-angle X-ray scattering (SAXS), enabling researchers to investigate an array of biological systems. These include skeletal and cardiac muscle fibers, connective tissues, amyloid aggregates, viruses, and macromolecules in solution, along with metal distributions within biological tissues.
The utility of such techniques at BioCAT extends into examining molecular machines—macromolecular assemblies that execute essential physiological functions. Many of these biological assemblies, composed of proteins and nucleic acids, resist crystallization and thus evade atomic-resolution study by conventional X-ray crystallography and cryo-electron microscopy. By harnessing synchrotron-generated X-rays and employing scattering approaches, BioCAT unlocks invaluable insights into the organization, structural configurations, and functional mechanisms of these dynamic complexes.
One of BioCAT’s defining scientific niches is its comprehensive program in muscle research, particularly involving the study of skeletal and cardiac muscle in both health and disease. The beamline at Sector 18-ID is uniquely outfitted for fiber diffraction—a technique especially suited for ordered fibrous biological materials like muscle tissue. Through detailed diffraction data, researchers can elucidate protein conformational changes, filament arrangements, and mutational impacts linked to inherited cardiomyopathies and other pathological conditions. This cutting-edge analysis capability places BioCAT at the forefront of biomedical research targeting muscular diseases at the molecular level.
The historical legacy of BioCAT underscores its value to the biomedical community. Operational since the latter part of the 1990s, BioCAT has served as a scientific hub not only for U.S.-based researchers but also for international investigators seeking access to unparalleled synchrotron resources. Access to beamtime at BioCAT is granted through a rigorous peer-reviewed proposal system under the APS General User Proposal framework. This meritocratic mechanism ensures that the most promising and scientifically sound projects gain entry, maintaining the facility’s role as a critical national research asset.
The impact of BioCAT’s work is clearly illustrated by its scholarly output. As of June 2024, the facility and its users have collectively published nearly 800 peer-reviewed scientific articles. These contributions have been cited over 58,000 times and have yielded an impressive h-index of 114—a metric demonstrating both the productivity and the high impact of the research conducted at this site. Such metrics signify BioCAT’s enormous influence across disciplines spanning muscle physiology, virology, biophysics, and macromolecular chemistry.
Illinois Institute of Technology’s Vice Provost for Research, Jeff Terry, emphasized this renewal’s significance: “This renewal affirms the importance of BioCAT as a national resource for biological and biomedical discovery. The facility gives researchers access to highly specialized X-ray scattering and diffraction capabilities that can answer questions not accessible by other methods, especially in systems such as muscle and other complex biological assemblies.” Such capabilities facilitate unparalleled investigations into the molecular underpinnings of life and disease, supporting the development of novel diagnostic and therapeutic strategies.
The recent upgrade to the Advanced Photon Source has further augmented BioCAT’s power and versatility. These enhancements expand the quality of beam coherence, brightness, and energy range, allowing BioCAT to pursue experiments that demand exquisite precision and sensitivity. Structural biology and biophysics researchers can now push boundaries by resolving dynamic processes in biomolecules with unprecedented clarity, driving new discoveries across biomedical fields.
BioCAT’s affiliation with the Illinois Tech Center for Synchrotron Radiation Research and Instrumentation, alongside faculty links to the Pritzker Institute of Biomedical Science and Engineering, provides an interdisciplinary environment fostering innovation. The NIH-supported facility forms an integral part of Illinois Tech’s expansive synchrotron research infrastructure, underlining a collaborative ecosystem where physics, biology, and engineering converge to probe fundamental questions about life at the atomic and molecular scales.
The significance of BioCAT’s continuation as a national research hub cannot be overstated. For scientists dedicated to mapping the architecture and functional dynamics of biological macromolecules, the facility’s tools and expertise are indispensable. As biomedical research increasingly targets complex, non-crystalline biological materials, BioCAT’s capabilities become ever more valuable, enabling breakthroughs in understanding diseases caused by structural protein mutations, viral mechanisms, and biomolecular interactions critical to health.
In summary, the renewed NIGMS funding ensures that BioCAT will sustain its mission to empower researchers investigating the molecular mechanisms of biological systems. This investment represents a foundational commitment to advancing biomedical discovery through synchrotron science, enabling the scientific community to unravel the intricacies of life’s molecular machinery and accelerating the development of next-generation therapies.
Work carried out at BioCAT is supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number 2P30GM138395. The findings and conclusions presented do not necessarily represent the official views of the NIH but reflect the dedication of the scientists and staff driving this major research infrastructure forward.
Subject of Research: Structural biology and biophysics focusing on X-ray scattering and diffraction studies of biological systems, including muscle, connective tissue, amyloids, and macromolecules in solution.
Article Title: BioCAT Secures $2.6 Million NIH Renewal to Advance Structural Biology Research at Argonne’s Advanced Photon Source
News Publication Date: June 2024
Web References:
- Biophysics Collaborative Access Team (BioCAT): https://www.bio.aps.anl.gov/
- Illinois Institute of Technology: https://www.iit.edu/
- National Institute of General Medical Sciences: https://www.nigms.nih.gov/
- Argonne National Laboratory: https://www.anl.gov/
Image Credits: Illinois Institute of Technology
Keywords
Biophysics, synchrotron radiation, X-ray scattering, fiber diffraction, small-angle X-ray scattering, structural biology, muscle research, Biomedical research, Advanced Photon Source, National Institute of General Medical Sciences, Argonne National Laboratory, biological macromolecules
